Nanostructured Lipid Carrier Gel Formulation of Recombinant Human Thrombomodulin Improve Diabetic Wound Healing by Topical Administration
Recombinant human thrombomodulin (rhTM), an angiogenesis factor, has been demonstrated to stimulate cell proliferation, keratinocyte migration and wound healing. The objective of this study was to develop nanostructured lipid carrier (NLC) formulations encapsulating rhTM for promoting chronic wound...
Saved in:
Main Authors: | Yuan-Shuo Hsueh (Author), Yan-Jye Shyong (Author), Hsiu-Ching Yu (Author), Shu-Jhen Jheng (Author), Shang-Wen Lin (Author), Hua-Lin Wu (Author), Jui-Chen Tsai (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients
by: Miyoshi S, et al.
Published: (2014) -
Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery
by: Sanjeevani Shekhar Deshkar, et al.
Published: (2021) -
Recombinant human soluble thrombomodulin improved lipopolysaccharide/d-galactosamine-induced acute liver failure in mice
by: Wataru Osumi, et al.
Published: (2015) -
Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
by: Yuki Asai, et al.
Published: (2020) -
Development of nanostructured bioplastic material for wound healing
by: Ilmira R. Gilmutdinova, et al.
Published: (2021)